HCPLive

Pollutant Exposure Tied to Cognitive Decline in Elderly

Long-term exposure to particulate matter (PM) (coarse PM: 2.5 to 10 µm in diameter [PM2.5-10] and fine PM: <2.5 µm in diameter [PM2.5]) is associated with faster cognitive decline in older women, according to a study published in the Feb. 13 issue of the Archives of Internal Medicine.

Jennifer Weuve, M.P.H., Sc.D., from the Rush University Medical Center in Chicago, and colleagues investigated long-term exposure to air pollution with PM2.5-10 and PM2.5 in relation to cognitive decline in a cohort of 19,409 U.S. women aged 70 to 81 years. Exposure to PM was estimated using geographic information system-based spatiotemporal smoothing models, prior to baseline cognitive testing. Cognition was evaluated via validated telephone assessments, administered three times, at approximately two-year intervals.

The investigators found that elevated levels of long-term exposure to PM2.5-10 and PM2.5 correlated with significantly faster cognitive decline. On a global score, two-year decline was 0.020 and 0.018 standard units worse for each 10 µg/m³ increase in exposure to PM2.5-10 and PM2.5, respectively. These differences in the cognitive trajectory were similar to those between women about two years apart in age in the cohort.

"Higher levels of exposure to ambient PM are associated with worse cognitive decline. Importantly, these associations were present at levels of PM exposure typical in many areas of the United States," the authors write. "If our findings are confirmed in other research, air pollution reduction is a potential means for reducing the future population burden of age-related cognitive decline, and eventually, dementia."

Abstract
Full Text (subscription or payment may be required)

Long-term exposure to particulate matter (coarse PM: 2.5 to 10 µm in diameter and fine PM: <2.5 µm in diameter) is associated with faster cognitive decline in older women, according to a study published in the Feb. 13 issue of the Archives of Internal Medicine.

Copyright © 2012 HealthDay. All rights reserved.

Most Popular

Recommended Reading

An experimental Ebola vaccine may have prevented the disease in a doctor who was at high risk of infection, according to a new report. The findings were published online March 5 in the Journal of the American Medical Association.
As more diabetes drugs hit the market there are natural safety questions that come with these prescriptions. In recent years the US Food and Drug Administration has worked to increase the steps taken to ensure the safety of these drugs.
Being free of heart disease risk factors in middle age greatly extends the number of years a person lives without heart failure, according to research to be presented March 14 at the annual meeting of the American College of Cardiology, held from March 14 to 16 in San Diego.
A mobile phone application has been released to identify current drug shortages, resolved shortages, or discontinuations of drug products, according to a press release published by the US Food and Drug Administration.
$vAR$